APA (7th ed.) Citation

Bamps, D., Blockeel, A. J., Dreesen, E., Marynissen, H., Laenen, J., Van Hecken, A., . . . Hoon, J. (2023). TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde‐Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology. Clinical pharmacology and therapeutics, 114(5), 1093-1103. https://doi.org/10.1002/cpt.3024

Chicago Style (17th ed.) Citation

Bamps, Dorien, et al. "TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde‐Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology." Clinical Pharmacology and Therapeutics 114, no. 5 (2023): 1093-1103. https://doi.org/10.1002/cpt.3024.

MLA (9th ed.) Citation

Bamps, Dorien, et al. "TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde‐Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology." Clinical Pharmacology and Therapeutics, vol. 114, no. 5, 2023, pp. 1093-1103, https://doi.org/10.1002/cpt.3024.